TrialInfection2024

Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind study.

Xiaoqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.